Top

World Journal of Urology

Published in:

01-05-2016 | Original Article

Quality assessment in prostate cancer centers certified by the German Cancer Society

Authors: Christoph Kowalski, Julia Ferencz, Peter Albers, Jan Fichtner, Thomas Wiegel, Günter Feick, Simone Wesselmann

Published in: World Journal of Urology | Issue 5/2016

Abstract

Purpose

In 2008, the German Cancer Society certification program for prostate cancer centers (PCCs) was introduced, fostering multidisciplinary and interprofessional cooperation. Since then, 97 PCCs have been certified. This paper describes the PCC certification program, quality indicators (QI) that are reported during certification, as well as changes over time and correlates of QI fulfillment.

Methods

Observational data from 70,683 primary prostate cancer (PCa) cases treated between 2010 and 2013 in certified PCC sites are analyzed using descriptive and correlation analyses.

Results

Fulfillment of the requirements is high with over 80 % of the sites fulfilling the requirements for most of the presented QIs with defined target values. Fulfillment increased slightly over time, with significant improvements in conducting multidisciplinary tumor conferences (increasing proportion of cases presented pre- and post-treatment, increasing participation of specialists), psycho-oncologic care, social service counseling and research participation. Bivariate associations between hospital characteristics and QIs observed were most distinct for time since first certification.

Conclusions

Results suggest that the PCC certification program presented contributes to establishing multidisciplinary teams over time and assures the provision of high-quality PCa care. However, differences in fulfillment of the requirements exist with regard to hospital characteristics beyond the scope of the certification system.

Robert-Koch-Institut, GeKiD (eds) (2013) Krebs in Deutschland 2009/2010, 9th edn. Robert-Koch-Institut, Berlin

Malvezzi M, Bertuccio P, Levi F, La Vecchia C, Negri E (2014) European cancer mortality predictions for the year 2014. Ann Oncol 25(8):1650–1656. doi:10.1093/annonc/mdu138 CrossRefPubMed

DeSantis CE, Lin CC, Mariotto AB, Siegel RL, Stein KD, Kramer JL, Alteri R, Robbins AS, Jemal A (2014) Cancer treatment and survivorship statistics, 2014. CA Cancer J Clin 64(4):252–271. doi:10.3322/caac.21235 CrossRefPubMed

Magnani T, Valdagni R, Salvioni R, Villa S, Bellardita L, Donegani S, Nicolai N, Procopio G, Bedini N, Rancati T, Zaffaroni N (2012) The 6-year attendance of a multidisciplinary prostate cancer clinic in Italy: incidence of management changes. BJU Int 110(7):998–1003. doi:10.1111/j.1464-410X.2012.10970.x CrossRefPubMed

Valicenti RK, Gomella LG, El-Gabry EA, Myers R, Nathan F, Strup S, Dicker A, McGinnis DE, Cardi G, Baltish M, Simirgliano M, Vizzard A, Mulholland SG (2000) The multidisciplinary clinic approach to prostate cancer counseling and treatment. Semin Urol Oncol 18(3):188–191PubMed

Sternberg CN, Krainer M, Oh WK, Bracarda S, Bellmunt J, Ozen H, Zlotta A, Beer TM, Oudard S, Rauchenwald M, Skoneczna I, Borner MM, Fitzpatrick JM (2007) The medical management of prostate cancer: a multidisciplinary team approach. BJU Int 99(1):22–27. doi:10.1111/j.1464-410X.2006.06477.x CrossRefPubMed

Gomella LG (2011) The prostate cancer unit: a multidisciplinary approach for which the time has arrived. Eur Urol 60(6):1197–1199. doi:10.1016/j.eururo.2011.08.023 CrossRefPubMed

Gomella LG, Lin J, Hoffman-Censits J, Dugan P, Guiles F, Lallas CD, Singh J, McCue P, Showalter T, Valicenti RK, Dicker A, Trabulsi EJ (2010) Enhancing prostate cancer care through the multidisciplinary clinic approach: a 15-year experience. J Oncol Pract 6(6):e5–e10. doi:10.1200/jop.2010.000071 CrossRefPubMedPubMedCentral

Valdagni R, Albers P, Bangma C, Drudge-Coates L, Magnani T, Moynihan C, Parker C, Redmond K, Sternberg CN, Denis L, Costa A (2011) The requirements of a specialist Prostate Cancer Unit: a discussion paper from the European School of Oncology. Eur J Cancer 47(1):1–7. doi:10.1016/j.ejca.2010.10.029 CrossRefPubMed

10.

Steffens JA, Ting O, Schmidt S, Albers P (2010) Certified prostate cancer centers of the German Cancer Society: current status 2 years after certification and future developments. Urologe 49(8):910–915. doi:10.1007/s00120-010-2301-0 CrossRefPubMed

11.

Deutsche Krebsgesellschaft (ed) (2014) Jahresbericht der zertifizierten Prostatakrebszentren. Deutsche Krebsgesellschaft, Berlin

12.

Leitlinienprogramm Onkologie (ed) (2011) Interdisziplinäre Leitlinie der Qualität S3 zur Früherkennung, Diagnose und Therapie der verschiedenen Stadien des Prostatakarzinoms, Version 2.0, AWMF registry: 043/022OL. Berlin

13.

Trinh QD, Bjartell A, Freedland SJ, Hollenbeck BK, Hu JC, Shariat SF, Sun M, Vickers AJ (2013) A systematic review of the volume–outcome relationship for radical prostatectomy. Eur Urol 64(5):786–798. doi:10.1016/j.eururo.2013.04.012 CrossRefPubMedPubMedCentral

14.

Follmann M, Schadendorf D, Kochs C, Buchberger B, Winter A, Wesselmann S (2013) Quality assurance for care of melanoma patients based on guideline-derived quality indicators and certification. J Dtsch Dermatol Ges 12(2):139–147PubMed

15.

Hearld LR, Alexander JA, Fraser I, Jiang HJ (2008) Review: how do hospital organizational structure and processes affect quality of care? A critical review of research methods. Med Care Res Rev 65(3):259–299. doi:10.1177/1077558707309613 CrossRefPubMed

16.

Hartrampf J, Ansmann L, Wesselmann S, Beckmann M, Pfaff H, Kowalski C (2014) Influence of patient and hospital characteristics on the performance of direct reconstruction after mastectomy. Frauenheilk 74(12):1128–1136. doi:10.1055/s-0034-1383400

17.

Aneja S, Yu JB (2012) The impact of county-level radiation oncologist density on prostate cancer mortality in the United States. Prostate Cancer Prostatic Dis 15(4):391–396. doi:10.1038/pcan.2012.28 CrossRefPubMed

18.

Ploussard G, Albrand G, Rozet F, Lang H, Paillaud E, Mongiat-Artus P (2014) Challenging treatment decision-making in older urologic cancer patients. World J Urol 32(2):299–308. doi:10.1007/s00345-013-1158-4 CrossRefPubMed

19.

Donabedian A (1966) Evaluating the quality of medical care. Milbank Q 44(3 Suppl):166–206CrossRef

20.

Singer S, Dieng S, Wesselmann S (2013) Psycho-oncological care in certified cancer centres—a nationwide analysis in Germany. Psychooncology 22(6):1435–1437. doi:10.1002/pon.3145 CrossRefPubMed

21.

Kowalski C, Ferencz J, Weis I, Adolph H, Wesselmann S (2015) Social service counseling in cancer centers certified by the German Cancer Society. Soci Work Health Care 54(4):307–319CrossRef

22.

Brundage M, Danielson B, Pearcey R, Bass B, Pickles T, Bahary JP, Peng Y, Wallace D, Mackillop W (2013) A criterion-based audit of the technical quality of external beam radiotherapy for prostate cancer. Radiother Oncol 107(3):339–345. doi:10.1016/j.radonc.2013.04.023 CrossRefPubMed

23.

Webber C, Brundage MD, Siemens DR, Groome PA (2013) Quality of care indicators and their related outcomes: a population-based study in prostate cancer patients treated with radiotherapy. Radiother Oncol 107(3):358–365. doi:10.1016/j.radonc.2013.04.017 CrossRefPubMed

24.

Merkow RP, Chung JW, Paruch JL, Bentrem DJ, Bilimoria KY (2014) Relationship between cancer center accreditation and performance on publicly reported quality measures. Ann Surg 259(6):1091–1097. doi:10.1097/sla.0000000000000542 CrossRefPubMed

25.

Kowalski C, Wesselmann S, Kreienberg R, Schulte H, Pfaff H (2012) The patientsʼ view on accredited breast cancer centers: strengths and potential for improvement. Geburtshilfe und Frauenheilkunde 72(2):137–143CrossRefPubMedPubMedCentral

26.

Klein J, von dem Knesebeck O (2015) Socioeconomic inequalities in prostate cancer survival: a review of the evidence and explanatory factors. Soc Sci Med 142:9–18CrossRefPubMed

Title: Quality assessment in prostate cancer centers certified by the German Cancer Society
Authors: Christoph Kowalski
Julia Ferencz
Peter Albers
Jan Fichtner
Thomas Wiegel
Günter Feick
Simone Wesselmann
Publication date: 01-05-2016
Publisher: Springer Berlin Heidelberg
Published in: World Journal of Urology / Issue 5/2016
Print ISSN: 0724-4983
Electronic ISSN: 1433-8726
DOI: https://doi.org/10.1007/s00345-015-1688-z

At a glance: The STEP trials

Springer Medicine

Quality assessment in prostate cancer centers certified by the German Cancer Society

Abstract

Purpose

Methods

Results

Conclusions

At a glance: The STEP trials

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 5/2016

Comment on: “Long-term outcomes of salvage lymph node dissection for clinically recurrent prostate cancer: results of a single-institution series with a minimum follow-up of 5 years”

Efficacy and safety of the first and repeated intradetrusor injections of abobotulinum toxin A 750 U for treating neurological detrusor overactivity

Is there a place for virtual reality simulators in assessment of competency in percutaneous renal access?

Clinically localized type 1 and 2 papillary renal cell carcinomas have similar survival outcomes following surgery

Evaluation of renal function in patients with a main renal stone larger than 1 cm and perioperative renal functional change in minimally invasive renal stone surgery: a prospective, observational study

The correlation between the electrode configuration and histopathology of irreversible electroporation ablations in prostate cancer patients